Authors:
Offstad, J
Schrumpf, E
Geiran, O
Soreide, O
Simonsen, S
Citation: J. Offstad et al., Plasma exchange and heart-liver transplantation in a patient with homozygous familial hypercholesterolemia, CLIN TRANSP, 15(6), 2001, pp. 432-436
Authors:
Wiencke, K
Spurkland, A
Schrumpf, E
Boberg, KM
Citation: K. Wiencke et al., Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles, HEPATOLOGY, 34(4), 2001, pp. 625-630
Authors:
Bjoro, K
Kirkegaard, P
Ericzon, BG
Friman, S
Schrumpf, E
Isoniemi, H
Herlenius, G
Olausson, M
Rasmussen, A
Foss, A
Hockerstedt, K
Citation: K. Bjoro et al., Is a 3-day limit for highly urgent liver transplantation for fulminant hepatic failure appropriate, and is the diagnosis in some cases incorrect?, TRANSPLAN P, 33(4), 2001, pp. 2511-2513
Authors:
Boberg, KM
Spurkland, A
Rocca, G
Egeland, T
Saarinen, S
Mitchell, S
Broome, U
Chapman, R
Olerup, O
Pares, A
Rosina, F
Schrumpf, E
Citation: Km. Boberg et al., The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis, SC J GASTR, 36(8), 2001, pp. 886-890
Authors:
Mitchell, SA
Grove, J
Spurkland, A
Boberg, KM
Fleming, KA
Day, CP
Schrumpf, E
Chapman, RW
Citation: Sa. Mitchell et al., Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis, GUT, 49(2), 2001, pp. 288-294
Authors:
Boberg, KM
Schrumpf, E
Bergquist, A
Broome, U
Pares, A
Remotti, H
Schjolberg, A
Spurkland, A
Clausen, OPF
Citation: Km. Boberg et al., Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development, J HEPATOL, 32(3), 2000, pp. 374-380
Authors:
Boberg, KM
Brosstad, F
Egeland, T
Egge, T
Schrumpf, E
Citation: Km. Boberg et al., Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy?, THROMB HAEM, 81(3), 1999, pp. 378-381
Authors:
Alvarez, E
Berg, PA
Bianchi, FB
Bianchi, L
Burroughs, AK
Cancado, EL
Chapman, RW
Cooksley, WGE
Czaja, AJ
Desmet, VJ
Donaldson, RT
Eddleston, ALWF
Fainboim, L
Heathcote, J
Homberg, JC
Hoofnagle, JH
Kakumu, S
Krawitt, EL
Mackay, IR
MacSween, RNM
Maddrey, WC
Manns, MP
McFarlane, IG
zum Buschenfelde, KHM
Mieli-Vergani, G
Nakanuma, Y
Nishioka, M
Penner, E
Porta, G
Portmann, BC
Reed, WD
Rodes, J
Schalm, SW
Scheuer, PJ
Schrumpf, E
Seki, T
Toda, G
Tsuji, T
Tygstrup, N
Vergani, D
Zeniya, M
Citation: E. Alvarez et al., International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis, J HEPATOL, 31(5), 1999, pp. 929-938
Authors:
Bjoro, K
Friman, S
Hockerstedt, K
Kirkegaard, P
Keiding, S
Schrumpf, E
Olausson, M
Oksanen, A
Isoniemi, H
Hjortrup, A
Bergan, A
Ericzon, BG
Citation: K. Bjoro et al., Liver transplantations in the Nordic countries, 1982-1998: Changes of indications and improving results, SC J GASTR, 34(7), 1999, pp. 714-722
Authors:
Spurkland, A
Saarinen, S
Boberg, KM
Mitchell, S
Broome, U
Caballeria, L
Ciusani, E
Chapman, R
Ercilla, G
Fausa, O
Knutsen, I
Pares, A
Rosina, F
Olerup, O
Thorsby, E
Schrumpf, E
Citation: A. Spurkland et al., HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations, TISSUE ANTI, 53(5), 1999, pp. 459-469
Authors:
Bjoro, K
Schrumpf, E
Bergan, A
Haaland, T
Skaug, K
Froland, SS
Citation: K. Bjoro et al., Liver transplantation for endstage hepatitis C cirrhosis in a patient withprimary hypogammaglobulinaemia, SC J IN DIS, 30(5), 1998, pp. 520-522